<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS99324</article-id>
<article-id pub-id-type="doi">10.1101/2020.10.20.347641</article-id>
<article-id pub-id-type="archive">PPR228328</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Amitai</surname>
<given-names>Assaf</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<aff id="A1">
<label>1</label>Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139</aff>
<aff id="A2">
<label>2</label>Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139</aff>
<aff id="A3">
<label>3</label>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">
<label>*</label>Correspondence: <email>amitaiassaf@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>20</day>
<month>10</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p>
</license>
<license license-type="open-access" xlink:href="https://europepmc.org/downloads/openaccess">
<license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The evolution of circulating viruses is shaped by their need to evade antibody response, which mainly targets the glycoprotein (spike). However, not all antigenic sites are targeted equally by antibodies, leading to complex immunodominance patterns. We used 3D computational models to estimate antibody pressure on the seasonal influenza H1N1 and SARS spikes. Analyzing publically available sequences, we show that antibody pressure, through the geometrical organization of spikes on the viral surface, shaped their mutability. Studying the mutability patterns of SARS-CoV-2 and the 2009 H1N1 pandemic spikes, we find that they are not predominantly shaped by antibody pressure. However, for SARS-CoV-2, we find that over time, it acquired mutations at antibody-accessible positions, which could indicate possible escape as define by our model. We offer a geometry-based approach to predict and rank the probability of surface resides of SARS-CoV-2 spike to acquire antibody escaping mutations.</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2</kwd>
<kwd>coronavirus</kwd>
<kwd>pandemic</kwd>
<kwd>influenza</kwd>
<kwd>glycoprotein</kwd>
<kwd>hemagglutinin</kwd>
<kwd>spike</kwd>
<kwd>molecular dynamics simulations</kwd>
<kwd>virus evolution</kwd>
<kwd>modeling</kwd>
<kwd>antibody pressure</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, is one of the most challenging global health crisis within the last century (<xref ref-type="bibr" rid="R1">1</xref>). The virus emerged as a result of a zoonotic shift (<xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref>). It is a member of the betacoronaviruses family (<xref ref-type="bibr" rid="R4">4</xref>), related to coronaviruses found in Bats (<xref ref-type="bibr" rid="R5">5</xref>), and to SARS CoV that cause severe respiratory syndrome (<xref ref-type="bibr" rid="R6">6</xref>) as well as other widely circulating members of the family that cause the common cold (<xref ref-type="bibr" rid="R7">7</xref>).</p>
<p id="P3">Coronaviruses (CoVs) have the largest genomes among RNA viruses (<xref ref-type="bibr" rid="R8">8</xref>). Nonstructural protein 14 (nsp14), a subunit of the replicase polyprotein encoded by CoVs is thought to provide a form of proofreading activity that could support the expansion of large CoVs genomes to their current size. One result of such proofreading activity is that CoVs genomes are less mutable compared to other RNA viruses (<xref ref-type="bibr" rid="R9">9</xref>), and thus the sequence diversity of SARS-CoV-2 is quite low (<xref ref-type="bibr" rid="R10">10</xref>).</p>
<p id="P4">In response to the SARS-CoV-2 pandemic, many approaches for antibody (Ab) therapies, and vaccines are being explored (<xref ref-type="bibr" rid="R11">11</xref>). Almost all vaccination approaches aim to use the glycoproteins or spike protein (S) of the virus in its trimeric form (<xref ref-type="bibr" rid="R12">12</xref>) or vaccinate with the full (inactivated) virus (<xref ref-type="bibr" rid="R13">13</xref>). The spike, a class I fusion protein, mediates entry to the host cell by binding to the angiotensin-converting enzyme 2 (ACE2) receptor (Ou et al., 2020) and is the main target of Ab response (Robbiani et al., 2020; Wu et al., 2020). These therapeutic approaches, hopefully, would be able to elicit strong Ab and T cell response against the virus. In particular, Abs against the spike receptor-binding domain (RBD) have been shown to have neutralization and protective capabilities (<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R15">15</xref>).</p>
<p id="P5">Since SARS-CoV-2 virus introduction into humans is recent, it probably has not yet evolved extensively to acquire escape mutations from the commutative Ab pressure of the human population (<xref ref-type="bibr" rid="R16">16</xref>). One mutation at the spike (D614G) is now widespread and is thought to support a high viral growth rate (<xref ref-type="bibr" rid="R17">17</xref>). However, other members of the coronavirus family have been circulating in human populations for many years (<xref ref-type="bibr" rid="R18">18</xref>) and evidence of antigenic drift is seen in SARS-CoV-1 (Guan et al., 2003; Song et al., 2005), and among common cold coronaviruses 229E (<xref ref-type="bibr" rid="R7">Chibo and Birch, 2006</xref>). Hence, given the prevalence of SARS-CoV-2, to inform vaccine design and understand how the fitness landscape of the virus evolves, it is important to recognize antigenic drift due to Ab pressure if it were to occur. More generally, antigenic drift due to Ab pressure is common in other RNA viruses such as the seasonal influenza virus (<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>).</p>
<p id="P6">Here we sought to understand and predict, from first principle, to what extent the mutability of the spikes of influenza and close relatives of SARS-CoV-2 could be attributed to Ab pressure. The magnitude (titers) of Ab response against a given epitope is a direct consequence of the B immunodominance hierarchy patterns of an immunogen, which are the result of various aspects of the humoral response to antigen (<xref ref-type="bibr" rid="R21">21</xref>–<xref ref-type="bibr" rid="R23">23</xref>). Amongst them is the B cell repertoire – the number of B cell clones targeting different epitopes (<xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R29">29</xref>), their germline affinity (<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R30">30</xref>), and T cell help to B cell (<xref ref-type="bibr" rid="R31">31</xref>). Here, we concentrate on the geometric presentation of the spike to Abs. We have previously shown using coarse-grained molecular dynamics simulations, that the geometry of the immunogen spike presentation on the virus recapitulates the known immunodominance of hemagglutinin (HA) head compared to its stem (<xref ref-type="bibr" rid="R24">24</xref>).</p>
<p id="P7">We developed here an in-silico approach to estimate the Ab targeting - a proxy for B cell immunogenicity (<xref ref-type="bibr" rid="R24">24</xref>), of residues on the spike surface, and the differential accessibility to antigenic epitopes due to the geometrical presentation of spikes on the surface of the virus. Superimposed on the spike surface, the immunogenicity score gives the <italic>Ab affinity maps</italic> of influenza and corona spikes, which we applied to predict how the antigenic space is explored unevenly across the surface of these glycoproteins. We then used sequences from public repositories (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>) to evaluate the <italic>mutability maps</italic> of those glycoproteins. Next, we developed a computational approach based on spectral clustering to compare these maps. We found that about 50% of the mutability maps variability of the S protein of the severe acute respiratory syndrome-related betacoronavirus (sarbecovirus), and 67% of the variability in the mutability of the seasonal influenza spike (HA) can be attributed Ab pressure, as estimated from the model. This suggests average, polyclonal Ab pressure was consequential in the diversification of the coronavirus sarbecovirus spike and the seasonal flu spike. Moreover, our data suggest that the geometry of spike presentation on the viral surface is a major factor determining its mutability.</p>
<p id="P8">We further studied the time evolution of SARS-CoV-2 spike mutability up to November 1<sup>st</sup>, 2020. While the overall correlation between our model and the mutability map is still low (correlation coefficient 0.46), we find that it has been gradually increasing over time. While very preliminary, it could suggest that some variants with Ab escape mutations are establishing in the population. Overall, our approach allows us to recognize from first principle, based on the 3D structure of glycoprotein and cryo-EM images of the viral surface, whether their mutational landscape has features suggesting Ab evasion, and rank surface residues according to their likelihood to acquire Ab-escaping mutations in the future. Importantly, this approach can detect early signs of SARS-CoV-2 and influenza adaptation to evade immune pressure by memory B cells.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<title>Geometry-dependent affinity of Abs to HA epitopes</title>
<p id="P9">The high-density presentation of spikes on the viral surface shelters, through steric impediments, immunologically recessive and conserved residues from Ab targeting – for example, residues belonging to the stem of HA (<xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R29">29</xref>, <xref ref-type="bibr" rid="R32">32</xref>). To study the relative accessibility of residues on the spike surface, we employed MD simulations to define how Ab on-rate, and hence affinity, could be modulated by the presentation of the spike. We first studied two geometrically distinct HA-presenting immunogens: 1) Presentation as soluble full-length HA trimer in its closed form [A/New Caledonia/20/1999 (NC99)] (<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R35">35</xref>) (<xref ref-type="fig" rid="F1">Figure 1A-i</xref>); 2) HA presentation within H1N1 influenza A (NC99) virus model (<xref ref-type="fig" rid="F1">Figure 1B-i</xref>) [See <xref ref-type="sec" rid="S9">Material and Methods</xref>]. For each presentation form, based on structural considerations, we computed the on-rate for Abs engaging different surface epitopes (<xref ref-type="fig" rid="F1">Figure 1A-ii, B-ii</xref>). The events occurred in the following sequence: 1] a single Ab arm first engages a target epitope; 2] the Ab molecule continues to fluctuate, allowing the second arm to target a second epitope, when the immunogen geometry is favorable, to bind it with a high rate, resulting in bivalent binding (<xref ref-type="supplementary-material" rid="SD1">S Figure 2A-B</xref>).</p>
<p id="P10">We superimposed the in-silico estimated affinity (on-rate of the first Ab arm) on HA structure to represent its <italic>affinity map</italic> (<xref ref-type="fig" rid="F1">Figure 1A-i, B-i</xref>). In the context of the free HA trimer presentation, we found that residues at convex sections on the spike surface were more accessible to the Ab, resulting in high affinity (<xref ref-type="fig" rid="F1">Figure 1A-ii</xref>). In the context of virus HA presentation (<xref ref-type="fig" rid="F1">Figure 1B-ii</xref>), similar behavior followed, and the density of spikes on the viral surface reduced the ability of the Ab to penetrate and interact with epitopes on the lower part of the spike, resulting in an affinity gradient of the Abs targeting residue along the main axis (<xref ref-type="fig" rid="F1">Figure 1B-ii</xref> right). Hence, presentation on the virus surface, as occurs in vivo, leads to an immunodominance or Ab pressure (targeting) gradient along the main axis of HA.</p>
</sec>
<sec id="S4">
<title>Antibody pressure directs the evolution of the seasonal flu</title>
<p id="P11">Viral infection elicits a humoral response and the production of Abs that target residues on the surface of glycoproteins. For circulating viruses to propagate in a population, they have to evade neutralization and recognition by Abs (<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R37">37</xref>). To do so, they accumulate mutations on their glycoproteins (<xref ref-type="bibr" rid="R38">38</xref>, <xref ref-type="bibr" rid="R39">39</xref>). Because sterically hidden residues are less accessible to Abs, we hypothesized their need to mutate is smaller compared to more accessible ones. Hence, we expected spike evolution and the mutational landscape to follow Ab pressure.</p>
<p id="P12">The influenza virus mutates from one year and the next, where most of the mutations are concentrated in five antigenic sites (Sa, Sb, Ca1, Ca2, Cb) located at the head of HA (<xref ref-type="bibr" rid="R40">40</xref>). Along with genetic drift, escape from neutralization by Abs is one of the main factors contributing to HA mutability (<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>). To examine the relationship between Ab pressure as defined by our model, and HA surface mutability, we studied the evolution of the seasonal influenza virus H1N1 using sequences dating back to 1918 (see <xref ref-type="sec" rid="S9">Material and Methods</xref>). Following alignment, we computed the entropy of each surface residue identified as an epitope (see <xref ref-type="sec" rid="S9">Material and Methods</xref>). The entropy <italic>H<sub>j</sub>
</italic> of residue <italic>j</italic> is given by <disp-formula id="FD1">
<label>(1)</label>
<mml:math id="M1">
<mml:mrow>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mstyle displaystyle="true">
<mml:munder>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>∈</mml:mo>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mtable columnalign="left">
<mml:mtr columnalign="left">
<mml:mtd columnalign="left">
<mml:mrow>
<mml:mtext>Amino acid in</mml:mtext>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr columnalign="left">
<mml:mtd columnalign="left">
<mml:mrow>
<mml:mtext>virus family</mml:mtext>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:msub>
<mml:mi>p</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mi>log</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>p</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mstyle>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where <italic>p<sub>j,i</sub>
</italic> is the probability of amino acid <italic>i</italic> to appear at residue <italic>j</italic> across the viral population (<xref ref-type="fig" rid="F1">Figure 1C-i</xref>). By superimposing the residue entropy on the surface of HA, we created its <italic>mutability map</italic> (<xref ref-type="fig" rid="F1">Figure 1C-ii</xref>). Interestingly, the mutability map is comparable to the affinity map computed for the virus presentation (<xref ref-type="fig" rid="F1">Figure 1B-ii</xref>), showing a pattern of diminishing mutability gradient along the main axis of the spike, but less so to the results for the trimer presentation (<xref ref-type="fig" rid="F1">Figure 1A-ii</xref>). This is corroborated by previous studies showing that the HA head acquires more mutation and evolves faster than its lower part – the stem (<xref ref-type="bibr" rid="R41">41</xref>).</p>
<p id="P13">We next quantified the similarity of the affinity and mutability maps. Because of the coarse-grained nature of our antibody model, we decided to aggregate close-by residues on the spike surface (<xref ref-type="fig" rid="F2">Figure 2A</xref>). As the surface features of the spike appeared to be an important factor in determining Ab affinity, we applied a non-linear mapping (manifold learning) algorithm - diffusion maps (<xref ref-type="bibr" rid="R42">42</xref>) on the epitopes’ positions and used the first three components (<xref ref-type="fig" rid="F2">Figure 2B</xref>). We then applied the k-means clustering algorithm (<xref ref-type="bibr" rid="R43">43</xref>) (spectral clustering) to aggregate residues in this space into epitope clusters (<xref ref-type="fig" rid="F2">Figure 2C</xref>). We computed for each epitope cluster <italic>k</italic> its entropy and affinity as follows: <disp-formula id="FD2">
<label>(2)</label>
<mml:math id="M2">
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>k</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mstyle displaystyle="true">
<mml:munder>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>∈</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mtext>Resiudes in cluster k</mml:mtext>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mstyle>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> <disp-formula id="FD3">
<label>(3)</label>
<mml:math id="M3">
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>A</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>f</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>k</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mstyle displaystyle="true">
<mml:munder>
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo>∈</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mtext>Resiudes in cluster k</mml:mtext>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:munder>
<mml:mrow>
<mml:msub>
<mml:mi>ω</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mstyle>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where <italic>C<sub>Ent,k</sub>
</italic> and <italic>C<sub>Aff,k</sub>
</italic> are the epitope cluster entropy and affinity respectively, <italic>N<sub>k</sub>
</italic> is the number of residues in cluster <italic>k</italic>, <italic>ω<sub>j</sub>
</italic> is the affinity (on-rate of the first Ab arm to epitope) to residue <italic>j</italic>, and the entropy <italic>H<sub>j</sub>
</italic> of residue <italic>j</italic> is given by <xref ref-type="disp-formula" rid="FD1">eq.(1)</xref>.</p>
<p id="P14">To assess the predictive strength of the computed affinity in explaining the observed mutability, we computed the correlation between <italic>C<sub>Aff,k</sub>
</italic> and <italic>C<sub>Ent,k</sub>
</italic> as a function of the cluster number (<xref ref-type="fig" rid="F2">Figure 2D</xref>). We find that the correlation values for HA virus presentation are high, with a maximum of 0.92 for 10 clusters, suggesting the in-silico model can explain a significant fraction of the mutability. Interestingly, the correlation value, regardless of cluster number, is always larger for the virus presentation than for the trimer (<xref ref-type="fig" rid="F2">Figure 2D</xref>), highlighting that spike evolution and escape due to Ab pressure occurs in the context of the virus - as a result, both mutability and Ab affinity vary most along the main axis of the spike.</p>
<p id="P15">To determine the optimal number of clusters <italic>k</italic> for comparison between the two maps, we first estimated the Total Within Sum of Squares for different cluster numbers (<xref ref-type="supplementary-material" rid="SD1">S Figure 5A</xref>) and used the elbow method to choose <italic>k</italic> = 60 (<xref ref-type="bibr" rid="R44">44</xref>). For <italic>k</italic> = 60, we found a correlation of 0.82 between <italic>C<sub>Ent,k</sub>
</italic> and <italic>C<sub>Aff,k</sub>
</italic>, suggesting that epitope cluster affinity, at this resolution, can explain 67% of the variability in the mutability map of HA.</p>
<p id="P16">Surprisingly, most epitope clusters that contain residues belonging to the five antigenic sites show a linear relation between their entropy and affinity, suggesting that the mutability of these sites simply follows from their position on HA, the geometry of its presentation on the viral surface, and is due to Ab pressure (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Epitope clusters containing conserved residues at the HA stem belonging to the HA Group 1 broadly neutralizing epitope (<xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R29">29</xref>, <xref ref-type="bibr" rid="R32">32</xref>) similarly align.</p>
<p id="P17">Taken together, these results suggest that the mutability of surface spike epitopes of circulating viruses can be described using a phase diagram (<xref ref-type="fig" rid="F2">Figure 2F</xref>). The mutability of epitope clusters that lay on a linear line of epitope cluster entropy vs. epitope cluster affinity is related to the average Ab pressure acting on these residues (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Epitope clusters below the line are more conserved than would be expected based on their accessibility to Ab pressure and could be due to the presence of functionally important sites. Epitope clusters above that line are more mutable than would be expected due to Ab pressure and may result from allosteric immune escape (<xref ref-type="bibr" rid="R45">45</xref>), escapes from CD8+ T cells (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>), glycosylation (<xref ref-type="bibr" rid="R48">48</xref>), or other factors.</p>
</sec>
<sec id="S5">
<title>The mutability map of the sarbecovirus spike follows geometry-dependent antibody pressure</title>
<p id="P18">Coronaviruses are capable of crossing the species barriers in zoonotic shifts resulting in the SARS-CoV pandemic in the year 2002-2004 and the 2012 MERS pandemic (<xref ref-type="bibr" rid="R4">4</xref>). To understand whether the geometrical principles controlling the distribution of mutation on the spike surface are general across species, we applied our computational model to study the mutability of the spike protein of close relatives of SARS-CoV-2 – the sarbecovirus subgenus. We considered two presentations of the corona spike (S protein) to Abs: 1) Presentation as soluble full-length S trimer in its closed form (<xref ref-type="bibr" rid="R49">49</xref>) (<xref ref-type="supplementary-material" rid="SD1">S Figure 3A-i</xref>); 2) S presentation on the coronavirus surface (<xref ref-type="fig" rid="F3">Figure 3A-i</xref>) [based on the cryo-EM structure of SARS that has 65 spikes on its surface (<xref ref-type="bibr" rid="R50">50</xref>) and SARS-CoV2 spike (<xref ref-type="bibr" rid="R49">49</xref>) (See <xref ref-type="sec" rid="S9">Material and Methods</xref>)].</p>
<p id="P19">We first used in-silico simulation to estimate the Ab affinity to surface residues of S, when presented as a trimer or the surface of the virus model (See <xref ref-type="sec" rid="S9">Material and Methods</xref>). Similarly to our observation for the Abs affinity against HA, we found an increased affinity to convex regions, an affinity gradient along the main axis of S for the virus presentation (<xref ref-type="fig" rid="F3">Figure 3A-ii</xref>), but not for the trimer presentation (<xref ref-type="supplementary-material" rid="SD1">S Figure 3A-ii</xref>). Next, we analyzed sequences of close relatives of the SARS-CoV-2 spike within the sarbecovirus subgenus (<xref ref-type="table" rid="T1">Table 1</xref>). Following alignment and construction of the phylogenetic tree (<xref ref-type="supplementary-material" rid="SD1">S Figure 4</xref>), we computed the mutational entropy of each surface residue identified as an epitope using <xref ref-type="disp-formula" rid="FD1">eq.(1)</xref> (<xref ref-type="fig" rid="F3">Figure 3B-i</xref>) and superimposed it on the spike surface to create its mutability map (<xref ref-type="fig" rid="F3">Figure 3B-ii</xref>). We observed that the most significant change in mutability is along the main axis of S. To quantitatively compare the affinity and mutability maps, we applied the diffusion map transformation on S and clustered the epitopes (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Studying the correlation value as a function of cluster size (<xref ref-type="fig" rid="F3">Figure 3D</xref>), we found that the correlation between the model and the mutability map is always higher for the virus spike presentation compared to the trimer, highlighting that the geometrical context in which Abs interact with the spike determines its mutability. We found a high degree of correlation (R=0.69) between <italic>C<sub>Ent,k</sub>
</italic> and <italic>C<sub>Aff,k</sub>
</italic>, suggesting that affinity as computed by our model, at this resolution, can explain 48% of the variability in the mutability map of S (<xref ref-type="fig" rid="F3">Figure 3E</xref>). The high degree of correlation between entropy and affinity suggests that average Ab pressure shaped, to the first order, the mutability of the sarbecovirus subgenus spike. While for seasonal influenza, the HA entropy (<xref ref-type="fig" rid="F1">Figure 1C</xref>) was the result of a gradual accumulation of mutations over time, S protein entropy (<xref ref-type="fig" rid="F3">Figure 3B</xref>) analyzed here is the result of a horizontal mutational process occurring simultaneously in different hosts, suggesting the virus evolves under similar geometrical immunoglobulin pressure.</p>
<p id="P20">The receptor-binding domain (RBD) is involved in the spike binding to ACE-2 (<xref ref-type="bibr" rid="R51">51</xref>, <xref ref-type="bibr" rid="R52">52</xref>). It has been shown that neutralizing Abs targeting the RBD can offer protection (<xref ref-type="bibr" rid="R14">14</xref>). Within the RBD, residues belonging to the receptor-binding motif (RBM) are most important in binding to ACE-2. We recognized epitope clusters to which residues part of the RBD and RBM belong (<xref ref-type="fig" rid="F3">Figure 3E</xref>). Many of the epitope clusters have both high entropy and high affinity, which could suggest mutations acquired at these key domains across the spike are due to evasion from Abs, as well as adaptation to the host-specific receptor. Several of the highly targeted and mutable epitope clusters are not part of the RBD. Hence, Abs targeting these residues will not necessarily offer neutralization activity. However, Abs targeting these clusters can control viral infection through non-neutralizing pathways (<xref ref-type="bibr" rid="R53">53</xref>), thereby motivating the virus to mutate these highly targeted parts.</p>
</sec>
<sec id="S6">
<title>SARS-CoV2 and the 2009 influenza pandemic spikes mutability is not predominantly due to antibody-pressure</title>
<p id="P21">Our analysis suggested that spike presentation geometry is an important factor governing the mutational entropy of viruses circulating either over long periods (influenza) or across species (sarbecoviruses). To find whether this observation can be generalized to pandemics, we computed the sequence entropy of HA for the 2009 flu pandemic H1N1 (sequences from (<xref ref-type="bibr" rid="R41">41</xref>), GISAID) (<xref ref-type="fig" rid="F4">Figure 4C-i</xref>). Superimposing the entropy on the HA structure (<xref ref-type="fig" rid="F4">Figure 4A-ii</xref>), we did not observe immunodominance gradient along the main axis of HA observed in the computational model (<xref ref-type="fig" rid="F1">Figure 1A-ii</xref>). Unlike for the mutability of seasonal flu, the correlation coefficient between epitope cluster pandemic entropy and epitope cluster affinity was low (0.18) (<xref ref-type="fig" rid="F4">Figure 4A-iii</xref>).</p>
<p id="P22">SARS-CoV-2 zoonotically shifted to humans in 2019 (<xref ref-type="bibr" rid="R5">5</xref>), probably from Bats via pangolins, although its precise evolutionary path is still unclear. Since then, it has spread in the human population, infecting more than 35 million people as of October 2020. Because of its proofreading capability, the virus evolution is slow. To analyze its total mutational entropy up to November 1<sup>st</sup>, 2020, we downloaded publically available SARS-CoV-2 sequences from GISAID (<ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>) (<xref ref-type="bibr" rid="R54">54</xref>) (sequences choice is discussed in Material and Methods), computed the sequence entropy (<xref ref-type="fig" rid="F4">Figure 4B-i</xref>), and superimposed it on the close structure of the spike (<xref ref-type="fig" rid="F4">Figure 4B-ii</xref>). Interestingly, the mutability map does not show the same gradient pattern as observed for the sarbecovirus subgenus spike entropy (<xref ref-type="fig" rid="F3">Figure 3B-ii</xref>). We applied the same clustering (<italic>k</italic> = 60) to compare the epitope cluster entropy and affinity and found a low value of the correlation coefficient (-0.047) (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Hence, the total sequence entropy of SARS-CoV-2 thus far is not dominanted by escape from Ab mutations.</p>
</sec>
<sec id="S7">
<title>Time evolution of SARS-CoV-2 mutability map</title>
<p id="P23">To see if we could observe changes in the evolution trend of the virus of the time, indicative of Ab escape mutations, we separated SARS-CoV-2 sequences into five groups based on the time at which they were captured: 1] before 02/2020, 2] 02/2020-06/2020, 3] 07/2020-08/2020, 4] 09/2020, and 5] 10/2020 (<xref ref-type="fig" rid="F4">Figure 4C-G</xref>). Computing the correlation coefficient between the Ab affinity map and the sequence entropy, we found a significant increase over time (<xref ref-type="fig" rid="F4">Figure 4H</xref>) from a value of -0.18 in Feb 2020 to 0.46 for sequences sampled during 10/2020. While the correlation value of 0.46 is still low, this may point that escape from Abs mutations are starting to be a more significant part of its population, in accordance with other reports (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R55">55</xref>). An increase over months and years in correlation value between the affinity map computed by our model and the evolving mutational landscape of SARS-CoV-2 could indicate that its mutability patterns are being shaped by Ab pressure. (See time dependence here <ext-link ext-link-type="uri" xlink:href="https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html">https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html</ext-link>).</p>
</sec>
</sec>
<sec id="S8" sec-type="discussion">
<title>Discussion</title>
<p id="P24">Humoral immunity is often characterized by dominant versus recessive responses to different epitopes on the same antigen. This hierarchy of B cell immunodominance depends on many factors, amongst them are the precursor frequency within the germline B cell repertoire, BCR affinity, and the steric accessibility or antigen geometry. Pathogens take advantage of antigen geometry to shield sites of vulnerability. Such is the case in influenza spike hemagglutinin, where conserved sites are located and the sterically hidden stem (<xref ref-type="bibr" rid="R56">56</xref>–<xref ref-type="bibr" rid="R58">58</xref>), or on HIV spike gp120 where the vulnerable and evolutionary conserved CD4 binding site position does not allow Abs to form bivalent interactions, reducing the effective affinity of Abs (<xref ref-type="bibr" rid="R59">59</xref>). While mature Abs are nevertheless capable of approaching sterically restricted sites via somatic hypermutations that could extend, for example, their CDR3 loops (<xref ref-type="bibr" rid="R60">60</xref>), immunogen shape and valency manipulates B cell immunodominance patterns, their selection process in the germinal center or the expansion of memory B cell population (<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R61">61</xref>, <xref ref-type="bibr" rid="R62">62</xref>). Because viruses must evade Ab response to survive, B cells immunodominance patterns could be a proxy to glycoprotein mutability, coupled through antigen geometry. Thus, we studied whether spike presentation geometry to Abs is a good predictor of their mutability. Using a coarse-grained model of an antibody, HA, and the S protein of SARS-CoV-2, in both trimer and viral presentation model system, we computed the Ab affinity maps as a proxy for Ab pressure on the spike. We used those maps to assess whether the magnitude of mutability at a cluster of sites is just what would be expected by geometrical considerations (<xref ref-type="fig" rid="F2">Figure 2F</xref>).</p>
<p id="P25">We found that for the seasonal flu spike – HA, geometry through the presentation on the virus could explain, to the first order, the mutability patterns at its surface. In particular, the mutability of the five antigenic sites is ordered as would be expected by the geometric restriction imposed by their position on the spike, as did the conserved group 1 epitope, which is functionally important for HA conformation change (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Hence, we speculate that rather than maintaining functionally important sites conserved by negatively selecting mutants at such sites, the virus positions functional sites at a location, where their acceptable mutational rate would be determined by their need to escape from targeting by the average polyclonal Ab response.</p>
<p id="P26">To understand whether a similar principle governs the mutability of coronaviruses, we created a similar coarse-grained model of the SARS CoV family. As coronaviruses do not mutate much, we decided to analyze its mutability across the virus sub-species, using sequences isolated from different hosts in the years 2003-2019. In mammalians, these viruses have to evade immunoglobulin response which we hypothesized would lead to geometrically similar escape patterns. We found that geometry, through Ab targeting, shapes to the first order the mutability patterns on the sarbecovirus subgenus spike map. Hence, these viruses evolve across various hosts under roughly geometrically-similar Ab pressure – at least the main axis of the virus seems to be the first, principles axis of mutability resulting from the density of spikes on the viral surface.</p>
<p id="P27">The mutational probability distribution we sampled for the sarbecovirus subgenus is analogous to sampling different “realizations” of the statistical ensemble of the sequence landscape of the viruses (<xref ref-type="bibr" rid="R63">63</xref>), where each realization is a viral from a different host. For the seasonal flu, we considered sequences over a large period - starting from 1918 and aggregate them to a single probability distribution analyzed. In both cases, presentation geometry roughly explained sequence entropy. Comparing both these approaches to describe mutability distribution is conceptually similar to the ergodic theorem in statistical physics, where the averages of a stochastic process sampled over time are equivalent to the averages computed over different statistical realizations. While evolution patterns of mutating viruses are not an ergodic system in general – as many mutants are not viable, and hence unreachable in the sequence space, the similar geometry of immunoglobulins and spike presentations could be is the reason our model works for both these different instances, with mutations distributed across time (for influenza), or across species (for sarbecoviruses). Statistical physics models have been previously used (<xref ref-type="bibr" rid="R64">64</xref>) to analyze the sequence space to compute the fitness landscape space of viruses (<xref ref-type="bibr" rid="R65">65</xref>, <xref ref-type="bibr" rid="R66">66</xref>). The overall fitness of viruses is often split into its intrinsic fitness of the virus and fitness component related to evasion from the immune response (i.e. Abs) (<xref ref-type="bibr" rid="R67">67</xref>). As our approach allows for rough estimation, from first principle, of the virus Ab-dependent element of the fitness, it can be used as a prior in inference methods of the intrinsic fitness.</p>
<p id="P28">Because of its proofreading mechanism, SARS-CoV-2 is not expected to mutate much. Nevertheless, since the SARS-CoV-2 pandemic has erupted, its sequences have been analyzed to detect mutations that would increase its fitness, infection capabilities, or allow it to escape from Abs (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R55">55</xref>, <xref ref-type="bibr" rid="R68">68</xref>). To see if we can find traces of escape due to Ab pressure on the SARS-CoV-2 spike, we compared its mutability map to our computed affinity map over time and found an increase in the correlation value since the beginning of the pandemic (<xref ref-type="fig" rid="F4">Figure 4H</xref>). While the correlation value of 0.46 computed for October 2020 is still low, it could suggest the spike starts to acquire some escape from Ab mutations. Since the RBD is involved in binding to ACE2, mutations at this domain could also modify the binding energy to the receptor. Interestingly, for the 2009 influenza pandemic, we found a low correlation value of 0.18. This could suggest that the 2009 flu pandemic has not been evolving for long enough under Ab pressure for the geometric pattern to be apparent and that the evolution of pandemic viruses is not, at least initially, directed by Ab pressure acting on their surface residues. It is more likely that mutations that accumulate in their spikes serve to increase their fitness and infecting capabilities in humans. Additionally, it is possible that pandemics do not elicit as strong a memory recall as seasonal/circulating viruses, and hence do not need to evolve as rapidly to escape Ab immune pressure.</p>
<p id="P29">We propose here a simple geometrical interpretation of the surface mutational landscape of that spike that could inform, based on sequences and the 3D structure alone, whether a dominant component of virus evolution is evasion from Abs. This technique could serve as an indicator of the evolutionary stage in the infection trajectory of a virus and whether it is on its way to becoming a circulating virus such as the seasonal flu.</p>
</sec>
<sec id="S9" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S10">
<title>The geometry of immunogens and epitope choice</title>
<p id="P30">The first input to our model was an atomistic description of the geometry of our immunogens, which we generated from available structural information and pdb files (<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R69">69</xref>). For HA and S, solvent-accessible residues were identified using pymol script “findSurfaceResidues” (<ext-link ext-link-type="uri" xlink:href="https://pymolwiki.org/index.php/FindSurfaceResidues">https://pymolwiki.org/index.php/FindSurfaceResidues</ext-link>), which identifies atoms with a solvent accessible area greater than or equal to 20 Ang<sup>2</sup> (HA) and 15 Ang<sup>2</sup> (S). We then find the residues to which those atoms belong to. This selection criterion gives a uniformly distributed set of residues on the face of HA and S (see <xref ref-type="supplementary-material" rid="SD1">S Figure 1A, B</xref>). A total of 184 epitopes (residues) were chosen for HA and 254 epitopes for S.</p>
<p id="P31">We constructed a simplified model of the influenza virus, in which 40 HA molecules are arranged in a fixed conformation on a sphere of radius equal to 16nm (a value chosen for computational tractability). The model recapitulates (<xref ref-type="bibr" rid="R24">24</xref>) the average spacing between adjacent HA on the influenza viral surface of ~ 14 nm (Harris et al., 2013). We also constructed a simplified model of the coronavirus based on the cryo-EM images of the SARS virus, in which 65 S molecules in closed form (<xref ref-type="bibr" rid="R49">49</xref>) are arranged in a fixed conformation on a sphere of radius equal to 87nm (<xref ref-type="bibr" rid="R50">50</xref>), resulting in a density of 0.27 spike pre 100nm<sup>2</sup>.</p>
<p id="P32">Steric constraints affect the access of antibodies to epitopes and this modifies the on-rate, thus modulating the affinity. To compute the relative magnitude of this effect for different epitopes presented by immunogens with different geometries, we employed MD simulations. In these simulations, a Lennard-Jones potential describes the interactions of antibodies with the immunogen atoms, and a separate Morse-potential is used to model interactions of the antigen binding region of the Ab to its specific cognate epitope (see <xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>). To estimate the steric effects alone, we first assumed that the affinity of Abs to all epitopes was equal in the absence of steric constraints. We then used MD simulations (Lammps software) (<xref ref-type="bibr" rid="R70">70</xref>) to compute the average time for the Ab antigen-binding region (<xref ref-type="supplementary-material" rid="SD1">S Figure 1C-D</xref>) to find the target epitope for the first time, which is called a “first passage time”. By running simulations multiple times, and then averaging over many simulations, we could estimate the mean first passage time to the epitope. The inverse of the mean first-passage time is the on-rate, and thus we computed the relative on-rates for Ab binding to different epitopes for different immunogen geometries. We take the on-rate of the first arm of the Ab model as a proxy for Ab affinity to a residue.</p>
</sec>
<sec id="S11">
<title>Coarse-grained model of the antibody</title>
<p id="P33">To estimate the encounter probability and rate of different residues on the surface on the immunogens by the Ab, we employed coarse-grained MD simulations. The B cell receptor is represented using 8 beads (see <xref ref-type="supplementary-material" rid="SD1">S Figure 1</xref>). We used a coarse-grained model of the Ag and Ab (see <xref ref-type="supplementary-material" rid="SD1">S Figure 1</xref>). In (<xref ref-type="bibr" rid="R71">71</xref>), a model of the Ab was suggested, built from ellipsoids and spheres. Here, we built our Ab model using spheres of different sizes to approximate the same dimension and flexibility of the Ab. The MD simulation system is composed of different beads (see <xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>). This size of the beads was chosen such that the distance between the two Fabs is approximately 15nm and the length of the Ab arm is 7nm (<xref ref-type="bibr" rid="R72">72</xref>). The size of the Fc region is chosen to be 5nm (<xref ref-type="bibr" rid="R73">73</xref>) (see <xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>). To construct the 7nm arm we use 3 beads (types 4,5,6 – <xref ref-type="supplementary-material" rid="SD1">S Figure 1B-C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>), where nearest-neighbor beads are connected with rigid bonds of length 1.75nm. Bead type 4 (arm hinge) is connected to bead 3 (Fc hinge) by a rigid bond of length 1.75nm. The epitope bead (type 7, <xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>) was chosen to have the same size as the Fab beads (1.75nm) (<xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>). The beads along the arm (type 4,5,6) are on a straight line (no kink), and the middle bead (type 6) is larger, to approximate the elongated ellipsoid shaped arm of the Ab (<xref ref-type="bibr" rid="R71">71</xref>).</p>
<p id="P34">The average angle between the two arms of the Ab fluctuate with a mean of 120 degrees and obeys the harmonic potential <disp-formula id="FD4">
<label>(S1)</label>
<mml:math id="M4">
<mml:mrow>
<mml:mi>U</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>θ</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mi>κ</mml:mi>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>θ</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>θ</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> with <italic>θ</italic>
<sub>0</sub> = 0.66 radians and <italic>κ</italic> = 10k<sub>b</sub>T /radian<sup>2</sup>, resulting in a relatively rigid model of the Ab (De Michele et al., 2016).</p>
<p id="P35">The system is integrated using a Langevin thermostat under “fix nve” to perform performs Brownian dynamics simulations (see <ext-link ext-link-type="uri" xlink:href="https://lammps.sandia.gov/doc/fix_langevin.html">https://lammps.sandia.gov/doc/fix_langevin.html</ext-link>).</p>
<p id="P36">The Fab bead interacts with the respective epitope bead via the Morse potential <disp-formula id="FD5">
<label>(S2)</label>
<mml:math id="M5">
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mo>=</mml:mo>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>α</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>r</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msup>
<mml:mo>−</mml:mo>
<mml:mn>2</mml:mn>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>−</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>α</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>r</mml:mi>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>r</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mtext> for </mml:mtext>
<mml:mi>r</mml:mi>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mi>r</mml:mi>
<mml:mi>c</mml:mi>
</mml:msub>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where <italic>r</italic>
<sub>0</sub> = 1.75nm which is the distance between the Fab bead and an epitope bead at which the LJ energy between them is zero, and the cutoff radius <italic>r<sub>c</sub>
</italic> = 2.2nm. <italic>D</italic>
<sub>0</sub> = 50 is the energy and the bond fluctuation scale <italic>α</italic> = 1nm<sup>−1</sup>: the Morse potential only serves to anchor the 1<sup>st</sup> arm to the epitope allowing the second arm to search for a second epitope.</p>
<p id="P37">The beads interact with the Lennard-Jones potential <disp-formula id="FD6">
<label>(S3)</label>
<mml:math id="M6">
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>4</mml:mn>
<mml:mi>ε</mml:mi>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>σ</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mi>r</mml:mi>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mn>12</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>−</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>σ</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mi>r</mml:mi>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>6</mml:mn>
</mml:msup>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mtext> for </mml:mtext>
<mml:mi>r</mml:mi>
<mml:mo>&lt;</mml:mo>
<mml:msub>
<mml:mi>r</mml:mi>
<mml:mi>c</mml:mi>
</mml:msub>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where <italic>ε</italic> = 1, <italic>σ<sub>i,j</sub>
</italic> is the interaction distance between beads i and j, and the cutoff radius is <italic>r<sub>c</sub>
</italic> = 2<sup>1/6</sup>
<italic>σ<sub>i,j</sub>
</italic>. The values of <italic>σ<sub>i,j</sub>
</italic> are detailed in <xref ref-type="supplementary-material" rid="SD1">Table S 2</xref>. The LJ interaction distance <italic>σ<sub>i,j</sub>
</italic> between all beads composing the Ab arm (types 4, 5, 6), and the epitope bead (type 7) is 1.75nm to construct the 7nm long arm. The LJ self-interaction distance of the Ab arm bead (type 6) was taken to be 4.2nm (<xref ref-type="supplementary-material" rid="SD1">Table S 1</xref>) to maintain an angle of approximately 120 degrees between the arms. The interaction distance of other pairs of beads is the sum of their radii (<xref ref-type="supplementary-material" rid="SD1">Table S 2</xref>).</p>
</sec>
<sec id="S12">
<title>Estimating the on-rates to the epitopes</title>
<p id="P38">The on-rate to each of the residues is estimated using MD simulations. Each simulation runs for a predetermined amount of time and we find the diffusion-limited first passage time of one of the Fabs to the neighborhood of the target residue. The on-rate for the first arm to find an epitope is given by <disp-formula id="FD7">
<label>(S4)</label>
<mml:math id="M7">
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>E</mml:mi>
<mml:mi>p</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>m</mml:mi>
<mml:mtext> </mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mstyle displaystyle="true">
<mml:munder>
<mml:mo>∑</mml:mo>
<mml:mi>i</mml:mi>
</mml:munder>
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>E</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mstyle>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where <italic>k</italic>
<sub>
<italic>on</italic>,1<italic>arm,Ep,i</italic>
</sub> is the on-rate estimated from simulation, <italic>i</italic>, for the Ab to find epitope <italic>Ep</italic>, and <italic>N<sub>Sim</sub>
</italic> is the number of independent simulations we perform. In a simulation where the Ab does not find its respective epitope we take <italic>k</italic>
<sub>
<italic>on</italic>,1<italic>arm,Ep,i</italic>
</sub> = 0. We perform independent MD simulations to estimate <italic>k</italic>
<sub>
<italic>on</italic>,1<italic>arm,Ep</italic>
</sub> for each epitope (7 independent simulations for the HA trimer, 12 for the influenza virus model, 17 independent simulations for the S protein trimer, 9 for the coronavirus model).</p>
<p id="P39">The on-rate for the binding of the second arm is given by <disp-formula id="FD8">
<label>(S5)</label>
<mml:math id="M8">
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>E</mml:mi>
<mml:mi>p</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>m</mml:mi>
<mml:mtext> </mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mstyle displaystyle="true">
<mml:munder>
<mml:mo>∑</mml:mo>
<mml:mi>i</mml:mi>
</mml:munder>
<mml:mrow>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mrow>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>m</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>E</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mstyle>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula> where in a simulation where the Ab does not find its epitope we take <italic>k</italic>
<sub>
<italic>on</italic>,2<italic>arm,Ep,i</italic>
</sub> = 0.</p>
</sec>
<sec id="S13">
<title>Viral sequences</title>
<p id="P40">The sequences analyzed here of the seasonal influenza H1N1 and the 2009 influenza pandemic are from (<xref ref-type="bibr" rid="R41">Kirkpatrick et al., 2018</xref>) - which originate from <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>. SARS-CoV-2 sequences were downloaded on November 8<sup>th,</sup> 2020 from <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>. Out of a total of 189550, only high quality (complete) sequences of length 1274 amino acid (135216 sequences) were analyzed. The consensus sequence of SARS-CoV-2 was calculated using the BLOSUM50 scoring matrix in Matlab. Sequences of the sarbecovirus subgenus were downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>. (see <xref ref-type="table" rid="T1">Table 1</xref>). The alignment of those sequences was done using ‘GONNET’ scoring matrix in Matlab. Find an interactive, time-dependent comparison of the mutability map to the affinity map model here <ext-link ext-link-type="uri" xlink:href="https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html">https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html</ext-link>.</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary information</label>
<media xlink:href="EMS99324-supplement-Supplementary_information.pdf" mimetype="application" mime-subtype="pdf" id="N67590" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S14">
<title>Acknowledgments</title>
<p>This work was supported by the National Institutes of Health, grant number 2U19AI057229-16. The author thanks A. K. Chakraborty, D. Lingwood, A, Seeber, J. P. Barton, and K. Dao Duc for their helpful discussions and comments. The author thanks O. Gal for his contribution to the SARS-CoV-2 time spike evolution comparison tool.</p>
</ack>
<sec id="S15" sec-type="data-availability">
<title>Code availability</title>
<p id="P41">The simulation and analysis code for this study are available at: <ext-link ext-link-type="uri" xlink:href="https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html">https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html</ext-link>.</p>
</sec>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P42">
<bold>Competing interests</bold>
</p>
<p id="P43">The author declares no competing.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>JF-W</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>K-H</given-names>
</name>
<name>
<surname>To</surname>
<given-names>KK-W</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>514</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>TT-Y</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y-W</given-names>
</name>
<name>
<surname>Shum</surname>
<given-names>MH-H</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J-F</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H-C</given-names>
</name>
<etal/>
</person-group>
<article-title>Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins</article-title>
<source>Nature</source>
<year>2020</year>
<volume>583</volume>
<issue>7815</issue>
<fpage>282</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10224</issue>
<fpage>565</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z-L</given-names>
</name>
</person-group>
<article-title>Origin and evolution of pathogenic coronaviruses</article-title>
<source>Nat Rev Microbiol</source>
<year>2019</year>
<volume>17</volume>
<issue>3</issue>
<fpage>181</fpage>
<lpage>92</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X-L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X-G</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>
<source>Nature</source>
<year>2020</year>
<volume>579</volume>
<issue>7798</issue>
<fpage>270</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drosten</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Günther</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Preiser</surname>
<given-names>W</given-names>
</name>
<name>
<surname>van der Werf</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brodt</surname>
<given-names>H-R</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome</article-title>
<source>New Engl J Med</source>
<year>2003</year>
<volume>348</volume>
<issue>20</issue>
<fpage>1967</fpage>
<lpage>76</lpage>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chibo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Birch</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains</article-title>
<source>J Gen Virol</source>
<year>2006</year>
<volume>87</volume>
<issue>5</issue>
<fpage>1203</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorbalenya</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Enjuanes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ziebuhr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Snijder</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Nidovirales: Evolving the largest RNA virus genome</article-title>
<source>Virus Research</source>
<year>2006</year>
<volume>117</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>37</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckerle</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Halpin</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Venter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<article-title>Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing</article-title>
<source>PLoS Pathog</source>
<year>2010</year>
<volume>6</volume>
<issue>5</issue>
<comment>e1000896</comment>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fauver</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Petrone</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Hodcroft</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Shioda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>AG</given-names>
</name>
<etal/>
</person-group>
<article-title>Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<issue>5</issue>
<fpage>990</fpage>
<lpage>6.e5</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 vaccines in development</article-title>
<source>Nature</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tostanoski</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mercado</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>McMahan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mahrokhian</surname>
<given-names>SH</given-names>
</name>
<etal/>
</person-group>
<article-title>DNA vaccine protection against SARS-CoV-2 in rhesus macaques</article-title>
<source>Science</source>
<year>2020</year>
<comment>eabc6284</comment>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Development of an inactivated vaccine candidate for SARS-CoV-2</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<issue>6499</issue>
<fpage>77</fpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications</article-title>
<source>medRxiv</source>
<year>2020</year>
<comment>2020.03.30.20047365</comment>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Robbiani</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Gaebler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Muecksch</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>JCC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Convergent antibody responses to SARS-CoV-2 in convalescent individuals</article-title>
<source>Nature</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<issue>5</issue>
<fpage>1284</fpage>
<lpage>94.e9</lpage>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Theiler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abfalterer</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<issue>4</issue>
<fpage>812</fpage>
<lpage>27.e19</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Hulswit</surname>
<given-names>RJG</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>CAM</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<chapter-title>Chapter Two - Coronavirus Spike Protein and Tropism Changes</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Ziebuhr</surname>
<given-names>J</given-names>
</name>
</person-group>
<source>Advances in Virus Research</source>
<publisher-name>Academic Press</publisher-name>
<year>2016</year>
<volume>96</volume>
<fpage>29</fpage>
<lpage>57</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das Suman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hensley Scott</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ince William</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brooke Christopher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Subba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Delboy Mark</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection</article-title>
<source>Cell Host &amp; Microbe</source>
<year>2013</year>
<volume>13</volume>
<issue>3</issue>
<fpage>314</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>IA</given-names>
</name>
</person-group>
<article-title>A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus</article-title>
<source>J Mol Biol</source>
<year>2017</year>
<volume>429</volume>
<issue>17</issue>
<fpage>2694</fpage>
<lpage>709</lpage>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahanty</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Prigent</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garraud</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Immunogenicity of infectious pathogens and vaccine antigens</article-title>
<source>BMC Immunol</source>
<year>2015</year>
<volume>16</volume>
<fpage>31</fpage>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angeletti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Angel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kosik</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hickman</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>GM</given-names>
</name>
<etal/>
</person-group>
<article-title>Defining B cell immunodominance to viruses</article-title>
<source>Nat Immunol</source>
<year>2017</year>
<volume>18</volume>
<issue>4</issue>
<fpage>456</fpage>
<lpage>63</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angeletti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yewdell</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage</article-title>
<source>Trends Immunol</source>
<year>2018</year>
<volume>39</volume>
<issue>7</issue>
<fpage>549</fpage>
<lpage>61</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Amitai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sangesland</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Rohrer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lonberg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lingwood</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Defining and Manipulating B cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses Against Influenza Virus</article-title>
<source>Cell System</source>
<year>2020</year>
<comment>In press</comment>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sangesland</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ronsard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kazer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Bals</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boyoglu-Barnum</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yousif</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group>
<article-title>Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus</article-title>
<source>Immunity</source>
<year>2019</year>
<volume>51</volume>
<issue>4</issue>
<fpage>735</fpage>
<lpage>49 e8</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbott</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Menis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Skog</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ota</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens</article-title>
<source>Immunity</source>
<year>2018</year>
<volume>48</volume>
<issue>1</issue>
<fpage>133</fpage>
<lpage>46 e6</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGuire</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Dreyer</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Carbonetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lippy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Glenn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scheid</surname>
<given-names>JF</given-names>
</name>
<etal/>
</person-group>
<article-title>HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies</article-title>
<source>Science</source>
<year>2014</year>
<volume>346</volume>
<issue>6215</issue>
<fpage>1380</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krammer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garcia-Sastre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palese</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Is It Possible to Develop a “Universal” Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine</article-title>
<source>Cold Spring Harb Perspect Biol</source>
<year>2018</year>
<volume>10</volume>
<comment>a028845(7):a028845</comment>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabel</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Fauci</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine</article-title>
<source>Nat Med</source>
<year>2010</year>
<volume>16</volume>
<issue>12</issue>
<fpage>1389</fpage>
<lpage>91</lpage>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dosenovic</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kara</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hartweger</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2018</year>
<volume>115</volume>
<issue>18</issue>
<fpage>4743</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>HX</given-names>
</name>
<name>
<surname>Jegaskanda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Juno</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Esterbauer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>HG</given-names>
</name>
<etal/>
</person-group>
<article-title>Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem</article-title>
<source>J Clin Invest</source>
<year>2019</year>
<volume>129</volume>
<issue>2</issue>
<fpage>850</fpage>
<lpage>62</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krammer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garcia-Sastre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palese</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Is It Possible to Develop a “Universal” Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine</article-title>
<source>Cold Spring Harb Perspect Biol</source>
<year>2018</year>
<volume>10</volume>
<issue>7</issue>
<comment>a028845</comment>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lingwood</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McTamney</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Yassine</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Whittle</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Boyington</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural and genetic basis for development of broadly neutralizing influenza antibodies</article-title>
<source>Nature</source>
<year>2012</year>
<volume>489</volume>
<issue>7417</issue>
<fpage>566</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaver</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Villar</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Kanekiyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nabel</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Mascola</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lingwood</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates</article-title>
<source>Nat Protoc</source>
<year>2016</year>
<volume>11</volume>
<issue>2</issue>
<fpage>193</fpage>
<lpage>213</lpage>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villar</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Kanekiyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wheatley</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Yassine</surname>
<given-names>HM</given-names>
</name>
<etal/>
</person-group>
<article-title>Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation</article-title>
<source>Sci Rep</source>
<year>2016</year>
<volume>6</volume>
<fpage>36298</fpage>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doud</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Hensley</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Bloom</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Complete mapping of viral escape from neutralizing antibodies</article-title>
<source>PLoS Pathog</source>
<year>2017</year>
<volume>13</volume>
<issue>3</issue>
<comment>e1006271</comment>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lanzavecchia</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Broadly Neutralizing Antiviral Antibodies</article-title>
<source>Annu Rev Immunol</source>
<year>2013</year>
<volume>31</volume>
<issue>1</issue>
<fpage>705</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Kwong</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Mascola</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Mechanism of Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment</article-title>
<source>J Virol</source>
<year>2009</year>
<volume>83</volume>
<issue>21</issue>
<fpage>10892</fpage>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hay</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YP</given-names>
</name>
</person-group>
<article-title>The evolution of human influenza viruses. Philosophical transactions of the Royal Society of London Series B</article-title>
<source>Biological sciences</source>
<year>2001</year>
<volume>356</volume>
<issue>1416</issue>
<fpage>1861</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caton</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brownlee</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Yewdell</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Gerhard</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)</article-title>
<source>Cell</source>
<year>1982</year>
<volume>31</volume>
<issue>2 Pt 1</issue>
<fpage>417</fpage>
<lpage>27</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkpatrick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Bahl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krammer</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The influenza virus hemagglutinin head evolves faster than the stalk domain</article-title>
<source>Scientific reports</source>
<year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>10432</fpage>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coifman</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Lafon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Maggioni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Warner</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Geometric diffusions as a tool for harmonic analysis and structure definition of data: diffusion maps</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2005</year>
<volume>102</volume>
<issue>21</issue>
<fpage>7426</fpage>
<lpage>31</lpage>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="confproc">
<person-group person-group-type="editor">
<name>
<surname>MacQueen</surname>
<given-names>J</given-names>
</name>
</person-group>
<source>Some methods for classification and analysis of multivariate observations</source>
<conf-name>Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability</conf-name>
<publisher-loc>Berkeley, Calif</publisher-loc>
<publisher-name>University of California Press</publisher-name>
<year>1967</year>
<volume>1</volume>
<comment>Statistics</comment>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tibshirani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Walther</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hastie</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Estimating the number of clusters in a data set via the gap statistic</article-title>
<source>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</source>
<year>2001</year>
<volume>63</volume>
<issue>2</issue>
<fpage>411</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sethi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Derdeyn</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein</article-title>
<source>PLOS Computational Biology</source>
<year>2013</year>
<volume>9</volume>
<issue>5</issue>
<fpage>e1003046</fpage>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troyer</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>McNevin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Krizan</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Abraha</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response</article-title>
<source>PLOS Pathogens</source>
<year>2009</year>
<volume>5</volume>
<issue>4</issue>
<fpage>e1000365</fpage>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barton</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Goonetilleke</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>McMichael</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable</article-title>
<source>Nat Commun</source>
<year>2016</year>
<volume>7</volume>
<issue>1</issue>
<comment>11660</comment>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SW</given-names>
</name>
<etal/>
</person-group>
<article-title>Glycans on influenza hemagglutinin affect receptor binding and immune response</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>
<volume>106</volume>
<issue>43</issue>
<fpage>18137</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walls</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y-J</given-names>
</name>
<name>
<surname>Tortorici</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Veesler</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<issue>2</issue>
<fpage>281</fpage>
<lpage>92.e6</lpage>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beniac</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Andonov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grudeski</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>TF</given-names>
</name>
</person-group>
<article-title>Architecture of the SARS coronavirus prefusion spike</article-title>
<source>Nat Struct Mol Biol</source>
<year>2006</year>
<volume>13</volume>
<issue>8</issue>
<fpage>751</fpage>
<lpage>2</lpage>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Baric</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus</article-title>
<source>J Virol</source>
<year>2020</year>
<volume>94</volume>
<issue>7</issue>
<fpage>e00127</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C-CD</given-names>
</name>
<name>
<surname>So</surname>
<given-names>RTY</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV</article-title>
<source>Science</source>
<year>2020</year>
<volume>368</volume>
<issue>6491</issue>
<fpage>630</fpage>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>Ms</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>Ms</given-names>
</name>
<name>
<surname>Stratov</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>HIV-specific antibody immunity mediated through NK cells and monocytes</article-title>
<source>Curr HIV Res</source>
<year>2013</year>
<volume>11</volume>
<fpage>388</fpage>
<lpage>406</lpage>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buckland-Merrett</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Data, disease and diplomacy: GISAID’s innovative contribution to global health</article-title>
<source>Glob Chall</source>
<year>2017</year>
<volume>1</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Weisblum</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>DaSilva</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poston</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>JCC</given-names>
</name>
<etal/>
</person-group>
<article-title>Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants</article-title>
<source>bioRxiv</source>
<year>2020</year>
<comment>2020.07.21.214759</comment>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altman</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Bennink</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Yewdell</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Herrin</surname>
<given-names>BR</given-names>
</name>
</person-group>
<article-title>Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity</article-title>
<source>eLife</source>
<year>2015</year>
<volume>4</volume>
<fpage>e07467</fpage>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterhoff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Guiding the long way to broad HIV neutralization</article-title>
<source>Curr Opin HIV AIDS</source>
<year>2017</year>
<volume>12</volume>
<issue>3</issue>
<fpage>257</fpage>
<lpage>64</lpage>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altman</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Angeletti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yewdell</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift</article-title>
<source>Viral Immunol</source>
<year>2018</year>
<volume>31</volume>
<issue>2</issue>
<fpage>142</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galimidi Rachel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Klein Joshua</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Politzer Maria</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seaman Michael</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nussenzweig Michel</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1</article-title>
<source>Cell</source>
<year>2015</year>
<volume>160</volume>
<issue>3</issue>
<fpage>433</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fera</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>H-X</given-names>
</name>
<name>
<surname>Kepler</surname>
<given-names>TB</given-names>
</name>
<etal/>
</person-group>
<article-title>Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2014</year>
<volume>111</volume>
<issue>28</issue>
<fpage>10275</fpage>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Haupt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Groschel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation <italic>In Vivo</italic>
</article-title>
<source>Immunity</source>
<year>2020</year>
<volume>53</volume>
<fpage>1</fpage>
<lpage>16</lpage>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanekiyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Yassine</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>McTamney</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Boyington</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Whittle</surname>
<given-names>JR</given-names>
</name>
<etal/>
</person-group>
<article-title>Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies</article-title>
<source>Nature</source>
<year>2013</year>
<volume>499</volume>
<issue>7456</issue>
<fpage>102</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson Andrew</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mann Jaclyn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Omarjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ndung’u</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Walker Bruce</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chakraborty Arup</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design</article-title>
<source>Immunity</source>
<year>2013</year>
<volume>38</volume>
<issue>3</issue>
<fpage>606</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sella</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hirsh</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>The application of statistical physics to evolutionary biology</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2005</year>
<volume>102</volume>
<issue>27</issue>
<fpage>9541</fpage>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louie</surname>
<given-names>RHY</given-names>
</name>
<name>
<surname>Kaczorowski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2018</year>
<volume>115</volume>
<issue>4</issue>
<fpage>E564</fpage>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kouyos</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Hinkley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Haddad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Whitcomb</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Petropoulos</surname>
<given-names>CJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Exploring the Complexity of the HIV-1 Fitness Landscape</article-title>
<source>PLoS Genet</source>
<year>2012</year>
<volume>8</volume>
<issue>3</issue>
<fpage>e1002551</fpage>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Łuksza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lässig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A predictive fitness model for influenza</article-title>
<source>Nature</source>
<year>2014</year>
<volume>507</volume>
<issue>7490</issue>
<fpage>57</fpage>
<lpage>61</lpage>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Genetic spectrum and distinct evolution patterns of SARS-CoV-2</article-title>
<source>medRxiv</source>
<year>2020</year>
<comment>2020.06.16.20132902</comment>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallagher</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>McCraw</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Torian</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Gulati</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>
<article-title>Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy</article-title>
<source>Vaccines (Basel)</source>
<year>2018</year>
<volume>6</volume>
<issue>2</issue>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plimpton</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Fast Parallel Algorithms for Short-Range Molecular Dynamics</article-title>
<source>J Comput Phys</source>
<year>1995</year>
<volume>117</volume>
<fpage>1</fpage>
<lpage>19</lpage>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Michele</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Los Rios</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Foffi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Piazza</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Simulation and Theory of Antibody Binding to Crowded Antigen-Covered Surfaces</article-title>
<source>PLoS Comput Biol</source>
<year>2016</year>
<volume>12</volume>
<issue>3</issue>
<fpage>e1004752</fpage>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bjorkman</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Few and Far Between: How HIV May Be Evading Antibody Avidity</article-title>
<source>PLOS Pathogens</source>
<year>2010</year>
<volume>6</volume>
<issue>5</issue>
<fpage>e1000908</fpage>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Leake</surname>
<given-names>MC</given-names>
</name>
</person-group>
<source>Single-Molecule Cellular Biophysics</source>
<publisher-loc>Cambridge</publisher-loc>
<publisher-name>Cambridge University Press</publisher-name>
<year>2013</year>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Meyerson</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Matsuoka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kuybeda</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bliss</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies</article-title>
<source>Proc Natl Acad Sci USA</source>
<year>2013</year>
<volume>110</volume>
<issue>12</issue>
<fpage>4592</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Antibody targeting and mutability of the hemagglutinin protein for the seasonal flu.</title>
<p>
<bold>(A-B)</bold> Coarse-grain model of the hemagglutinin trimer of A/New Caledonia/20/1999 (NC99) H1N1 influenza protein in its closed form (A). The virus has 40 HA molecules at a spike spacing of 14.8 nm. [Measured spike spacing on influenza is 14 nm (<xref ref-type="bibr" rid="R74">74</xref>)] (B). For each immunogen geometry (trimer - A or full virus - B), a detailed atomistic structure of the immunogen is coarse-grained and presented in rainbow colors (panel i). Here every colored bead on the immunogen is a residue, representing a different HA epitope (184 different possible sites on trimeric HA). The antibody structure is presented as the Fc (blue bead), and two antigen binding sites (magenta beads). Panels ii within A-B depict coarse-grained simulations for the Ab affinity (on-rate of Ab first arm binding – see <xref ref-type="disp-formula" rid="FD7">eq.(S4)</xref>) to these residues. The affinity estimated from the simulation is superimposed on the HA structure. Top view (left), side view (right). The affinity to cyan sites is high, intermediate to white sites, low for purple sites, and was the average over multiple simulations. <bold>(C)</bold> Panel i depicts the entropy (see <xref ref-type="disp-formula" rid="FD1">eq.(1)</xref>) of HA epitopes computed for the seasonal flu (pre-pandemic influenza H1N1 (1918–1957 and 1977–2009) (sequences from (<xref ref-type="bibr" rid="R41">41</xref>)). Panel ii shows the entropy of the residues superimposed on HA structure, where highly mutable residues are in cyan, intermediate in white and conserved sites in purple.</p>
</caption>
<graphic xlink:href="EMS99324-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Antibody pressure guided the mutability of the hemagglutinin.</title>
<p>
<bold>(A)</bold> HA protein. Each circle corresponds to a surface residue (epitope) and has a different color. <bold>(B)</bold> 2d projections of the first four eigenvectors of the epitope positions following diffusion map decompositions. <bold>(C)</bold> Surface residues (epitopes) were clustered using k-means clustering algorithm applied to spectral decomposition shown in B. Same color-coding as in (A) <bold>(D)</bold> The correlation coefficient between epitope cluster entropy (<xref ref-type="disp-formula" rid="FD2">eq.(2)</xref>) and the epitope cluster affinity (<xref ref-type="disp-formula" rid="FD3">eq.(3)</xref>), as a function of cluster number, computed for HA in the virus presentation depicted in <xref ref-type="fig" rid="F1">Figure 1B</xref> (blue), and at the trimer presentation depicted in <xref ref-type="fig" rid="F1">Figure 1A</xref> (red). <bold>(E)</bold> Scatter plot of the epitope clusters entropy computed for the seasonal influenza H1N1 vs. the epitope clusters affinity. The correlation coefficient between them is 0.82. Marked are clusters containing residues belonging to the five known antigenic sites of flu (Cb - green, Sa - yellow, Sb - blue, Ca1 - cyan, Ca2 - red). Also marked is the group 1 conserved broadly neutralizing antibodies epitope (purple). (The number of clusters is 60). <bold>(F)</bold> Schematic of the relationship between entropy and computed Ab affinity for circulating viruses evolving under Ab pressure.</p>
</caption>
<graphic xlink:href="EMS99324-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Antibody targeting and mutability of the sarbecovirus subgenus spike.</title>
<p>
<bold>(A)</bold> SARS-CoV-2 spike (S) protein in its closed form (<xref ref-type="bibr" rid="R49">49</xref>) arranged on a sphere to create a virus model. The virus model has 65 S molecules at a density of 0.27 spikes per 100nm<sup>2</sup> (<xref ref-type="bibr" rid="R50">50</xref>). A detailed atomistic structure of the spike is coarse-grained and presented in rainbow colors (panel i). Every colored bead on the spike is a residue, representing a different S epitope (254 different possible sites on trimeric S). Panel ii depicts coarse-grained simulations for the Ab affinity to these residues (see <xref ref-type="fig" rid="F1">Figure 1A-ii</xref> for definition and color-coding). <bold>(B)</bold> Panel i depicts the entropy (see <xref ref-type="disp-formula" rid="FD1">eq.(1)</xref>) of each spike residue computed for the sarbecovirus subgenus spike (see <xref ref-type="table" rid="T1">Table 1</xref>). Panel ii shows the entropy of the residues superimposed on the spike structure. Same color-coding as in <xref ref-type="fig" rid="F1">Figure 1C-ii</xref>. <bold>(C)</bold> Pane i. The spike protein of the coronavirus. Each circle corresponds to a surface residue (epitope) and has a different color. Panel ii. 2d projections of the first four eigenvectors of the epitope positions following diffusion map decompositions. Pane iii. Clustering of the surface residues of the spike protein using k-means clustering algorithm applied to the spectral decomposition shown in panel ii (<italic>k</italic> = 60). <bold>(D)</bold> The correlation coefficient between epitope cluster entropy (<xref ref-type="disp-formula" rid="FD2">eq.(2)</xref>) and the epitope cluster affinity (<xref ref-type="disp-formula" rid="FD3">eq.(3)</xref>), as a function of cluster number, computed for the corona spike in the virus presentation (blue), and at the trimer presentation (red). (see <xref ref-type="supplementary-material" rid="SD1">S Figure 3</xref> for the trimer presentation affinity map) <bold>(E)</bold> Scatter plot of the epitope clusters entropy, computed for the sarbecovirus spike vs. the epitope cluster affinity estimated from the simulations. The correlation coefficient between them is 0.69. Clusters that contain residues belonging to the RBD are in green and those containing residues belonging to the RBM are in red. (The number of clusters is 60).</p>
</caption>
<graphic xlink:href="EMS99324-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Spike evolution of the 2009 influenza pandemic and SARS-CoV-2.</title>
<p>Comparison of the mutational variance of sequences (mutability map) and the affinity maps computed from the computational model. For A-B, panel i depicts the residue entropy as a function at different positions. For A-B, panel ii depicts the entropy of the residues is superimposed on the spike. Same color coding as in <xref ref-type="fig" rid="F1">Figure 1C-ii</xref>. Panel iii. Scatter plot of the entropy of epitope clusters, against the epitope cluster affinity computed for the spike. <bold>(A)</bold> Sequence entropy of HA for the pandemic flu H1N1 (2009–2017) (sequences taken from <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>, and (<xref ref-type="bibr" rid="R41">41</xref>)). The correlation coefficient between the epitope cluster entropy and affinity is R=0.18. <bold>(B)</bold> (i) Sequence entropy of the S spike protein of SARS-CoV-2 computed for all S protein sequences up-to October 31<sup>th</sup> 2020 (sequences downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>). (ii) The correlation coefficient between the epitope cluster entropy and epitope cluster affinity is R=-0.076. Same legend as <xref ref-type="fig" rid="F3">Figure 3E</xref>. <bold>Time-dependence of SARS-CoV-2 sequence entropy.</bold> The entropy of the S spike protein of SARS-CoV-2 computed for sequences collected at 5 time periods since the beginning of the pandemic (panel i) and correlation to the computationally derived affinity map, following epitope clustering (panel ii) (same clusters as those shown and used in <xref ref-type="fig" rid="F3">Figure 3C-iii, E</xref>). <bold>(C)</bold> up to February 1st 2020, R=-0.18, <bold>(D)</bold> February-June 2020, R=-0.089 <bold>(E)</bold> July-August 2020, R=0.26, <bold>(F)</bold> September 2020, R=0.37, <bold>(G)</bold> October 2020, R=0.46. <bold>(H)</bold> The correlation coefficient as a function of time. (Find an interactive, comparison of the time-dependent mutability map to the affinity map here <ext-link ext-link-type="uri" xlink:href="https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html">https://amitaiassaf.github.io/SpikeGeometry/SARSCoV2EvoT.html</ext-link>).</p>
</caption>
<graphic xlink:href="EMS99324-f004"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Sarbecovirus.</title>
<p>Species used for the analysis detailed in <xref ref-type="fig" rid="F1">Figure 1C</xref>.</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Coronavirus Species</th>
<th valign="top" align="left">Collection date</th>
<th valign="top" align="left">Reference</th>
<th valign="top" align="left">Isolation origin</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">SARS-CoV-2 consensus</td>
<td valign="top" align="left">2019-2020</td>
<td valign="top" align="left">Computed in this manuscript</td>
<td valign="top" align="left">Human</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus RaTG13</td>
<td valign="top" align="left">2013</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/QHR63300.2">https://www.ncbi.nlm.nih.gov/protein/QHR63300.2</ext-link>
</td>
<td valign="top" align="left">Rhinolophus affinis</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus Urbani</td>
<td valign="top" align="left">May 2003</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAP13441">https://www.ncbi.nlm.nih.gov/protein/AAP13441</ext-link>
</td>
<td valign="top" align="left">Human</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus CUHK-W1</td>
<td valign="top" align="left">2003</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAP13567.1">https://www.ncbi.nlm.nih.gov/protein/AAP13567.1</ext-link>
</td>
<td valign="top" align="left">Human</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus GZ02</td>
<td valign="top" align="left">2003</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAS00003">https://www.ncbi.nlm.nih.gov/protein/AAS00003</ext-link>
</td>
<td valign="top" align="left">Human</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus A031</td>
<td valign="top" align="left">2004</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAV97988.1">https://www.ncbi.nlm.nih.gov/protein/AAV97988.1</ext-link>
</td>
<td valign="top" align="left">Raccoon dogs</td>
</tr>
<tr>
<td valign="top" align="left">Bat coronavirus A022</td>
<td valign="top" align="left">2004</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAV98003.1">https://www.ncbi.nlm.nih.gov/protein/AAV98003.1</ext-link>
</td>
<td valign="top" align="left">Raccoon dogs</td>
</tr>
<tr>
<td valign="top" align="left">Bat SARS-like ZXC21</td>
<td valign="top" align="left">2015</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AVP78042.1">https://www.ncbi.nlm.nih.gov/protein/AVP78042.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus sinicus</td>
</tr>
<tr>
<td valign="top" align="left">Bat SARS-like ZC45</td>
<td valign="top" align="left">2017</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AVP78031.1">https://www.ncbi.nlm.nih.gov/protein/AVP78031.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus sinicus</td>
</tr>
<tr>
<td valign="top" align="left">Bat SARS-like CoV Rp3/2004</td>
<td valign="top" align="left">2004</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AAZ67052.1">https://www.ncbi.nlm.nih.gov/protein/AAZ67052.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus ferrumequinum</td>
</tr>
<tr>
<td valign="top" align="left">SARS coronavirus Rs 672/2006</td>
<td valign="top" align="left">2006</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/ACU31032.1">https://www.ncbi.nlm.nih.gov/protein/ACU31032.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus sinicus</td>
</tr>
<tr>
<td valign="top" align="left">Bat SARS-like coronavirus WIV1</td>
<td valign="top" align="left">2012</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGZ48828.1">https://www.ncbi.nlm.nih.gov/protein/AGZ48828.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus sinicus</td>
</tr>
<tr>
<td valign="top" align="left">SARS-like coronavirus WIV16</td>
<td valign="top" align="left">2013</td>
<td valign="top" align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/protein/ALK02457.1">https://www.ncbi.nlm.nih.gov/protein/ALK02457.1</ext-link>
</td>
<td valign="top" align="left">Rhinolophus sinicus</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
